5[1]Langtry HD,Balfour JA.Glimepinide in the treatment of type non-insulin dependent diabetes.Drugs,1998,55(4):563-569
6[2]Malaisse WJ.Stimulation of insulin release by non-sulfonylurea hypoglycemic agents:the meglitinide family.Horm Metab Res,1995,27:263
7[3]Hofmann CA,Colca JR.The pharmacodynamics and activity of α-glucosidace inhibition J.Diabetes Care,1992,15:1075-1078
8[4]Bischoff H.New Pharmacological approaches to therapy of NIDDM.European J Clin Invest,1994,24(3):28-34
9[14]Gromada J.Effects of the hypoglycemic drugs repaglinide and glibenclamide on ATP-sensitive poyassium channels cytosotic calcium levels in beta TC3 cell and ratpancreatic beta cells.Diabetologia,1995,38:1025
10[16]Mulec H.Efficacy and safety compared to enapril in patients with stable renal insufficiency.Kidney International,1994,45(suppl):141
